Atypical Endometrial Hyperplasia
Showing 1 - 25 of 3,439
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet
Recruiting
- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
- statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 22, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma Stage I
- Medroxyprogesterone acetate + Atorvastatin
-
Peking, Beijing, ChinaWang Jianliu
Dec 29, 2022
Endometrial Hyperplasia Trial in Winston-Salem (Megestrol Acetate, Levonorgestrel Drug Implant)
Recruiting
- Endometrial Hyperplasia
- Megestrol Acetate
- Levonorgestrel Drug Implant
-
Winston-Salem, North CarolinaWake Forest Baptist Health Sciences
Aug 5, 2022
Atypical Endometrial Hyperplasia Trial in Shanghai (Metformin plus Megestrol acetate, Megestrol Acetate)
Terminated
- Atypical Endometrial Hyperplasia
- Metformin plus Megestrol acetate
- Megestrol Acetate
-
Shanghai, Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Mar 24, 2022
Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)
Not yet recruiting
- Endometrial Carcinoma Stage I
- Atypical Endometrial Hyperplasia
- No intervention
- (no location specified)
Dec 3, 2022
Endometrial Tumors, Atypical Endometrial Hyperplasia, Progesterone Resistance Trial in Shanghai (GnRHa, Letrozole 2.5mg,
Recruiting
- Endometrial Neoplasms
- +2 more
- GnRHa
- +3 more
-
Shanghai, Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Jul 29, 2022
Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity Trial in Shanghai (Intensive Lifestyle Intervention
Recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- Intensive Lifestyle Intervention (ILI)
- +2 more
-
Shanghai, ChinaObstetrics and Gynecology Hospital of Fudan University
Jun 17, 2022
Atypical Endometrial Hyperplasia, Obesity, Fertility Issues Trial in Shanghai (levonorgestrel-releasing intrauterine system,
Recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- levonorgestrel-releasing intrauterine system
- Polyethylene Glycol Loxenatide
-
Shanghai, Shanghai, ChinaObstetrics & Gynecology Hospital of Fudan University
Jan 14, 2022
Atypical Endometrial Hyperplasia Trial in Shanghai (Megestrol Acetate, Rosuvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Megestrol Acetate
- Rosuvastatin
-
Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Aug 17, 2021
Complex Atypical Hyperplasia, Endometrial Cancer Trial in Chapel Hill, Cincinnati (Metformin)
Recruiting
- Complex Atypical Hyperplasia
- Endometrial Cancer
-
Chapel Hill, North Carolina
- +1 more
Jan 18, 2023
Endometrial Cancer, Atypical Endometrial Hyperplasia Trial in Chengdu (Progesterone, Mirena®, GnRH agonist)
Recruiting
- Endometrial Cancer
- Atypical Endometrial Hyperplasia
- Progesterone
- +2 more
-
Chengdu, Sichuan, ChinaWest China Second University Hospital
Sep 3, 2021
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Trial in Duarte (Megestrol Acetate, Pterostilbene)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma
- Megestrol Acetate
- Pterostilbene
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid
Recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- Everolimus
- +2 more
-
Greeley, Colorado
- +17 more
Jun 13, 2022
Complex Atypical Hyperplasia, Endometrial Cancer Trial in Chapel Hill (18F-fluorofuranylnorprogesterone PET / MRI)
Not yet recruiting
- Complex Atypical Hyperplasia
- Endometrial Cancer
- 18F-fluorofuranylnorprogesterone PET / MRI
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Jul 28, 2022
Atypical Endometrial Hyperplasia, Obese, Fertility Issues Trial (Liraglutide Injection, Megestrol Acetate 160 MG)
Withdrawn
- Atypical Endometrial Hyperplasia
- +2 more
- Liraglutide Injection
- Megestrol Acetate 160 MG
- (no location specified)
Mar 23, 2021
Endometrial Hyperplasia, Endometrial Cancer, Gynecologic Cancer Trial in Vancouver (Hysteroscopic uterine resection)
Recruiting
- Endometrial Hyperplasia
- +2 more
- Hysteroscopic uterine resection
-
Vancouver, British Columbia, CanadaVancouver General Hospital
Oct 14, 2021
Endometrial Hyperplasia Without Atypia Trial in Kocaeli (Vaginal Micronized Progesterone, Levonorgestrel-Intrauterine System)
Completed
- Endometrial Hyperplasia Without Atypia
- Vaginal Micronized Progesterone
- Levonorgestrel-Intrauterine System
-
Kocaeli, TurkeyKocaeli University
Dec 1, 2020
Endometrial Atypical Hyperplasia, Endometrial Adenocarcinoma Trial in Shanghai, Hangzhou (Megestrol acetate and metformin,
Completed
- Endometrial Atypical Hyperplasia
- Endometrial Adenocarcinoma
- Megestrol acetate and metformin
- Megestrol acetate
-
Shanghai, Shanghai, China
- +4 more
Sep 10, 2021
Endometrial Tissues and Mononuclear Cells Receptivity in
Completed
- Endometrial Hyperplasia Without Atypia
- +6 more
- endometrial tissue and peripheral blood mononuclear cells receptivity
- (no location specified)
Oct 29, 2023
Endometrial Changes in Breast Cancer Women.
Active, not recruiting
- Endometrial Cancer
- +3 more
- Hysteroscopy
-
Rome, Lazio, ItalyIRCCS "Regina Elena" National Cancer Institute
Jan 29, 2023
Atypical Endometrial Hyperplasia Trial in Shanghai (Megestrol Acetate, Levonorgestrel-releasing Intrauterine System(LNG-IUS))
Completed
- Atypical Endometrial Hyperplasia
- Megestrol Acetate
- Levonorgestrel-releasing Intrauterine System(LNG-IUS)
-
Shanghai, Shanghai, ChinaObstetrics and Gynecology Hospital, Fudan University
Jun 18, 2020
Moesin in Endometrial Hyperplasia and Endometrial Carcinoma
Not yet recruiting
- Endometrial Cancer and Endometrial Hyperplasia
- microscopic pathological evaluation
-
Sohag, EgyptSohag University Hospital
Nov 8, 2022
Endometrial Hyperplasia, Grade 1 Endometrial Cancer Trial in Saint Louis, Albuquerque, Oklahoma City (Telemedicine behavioral
Not yet recruiting
- Endometrial Hyperplasia
- Grade 1 Endometrial Cancer
- Telemedicine behavioral weight intervention
- +3 more
-
Saint Louis, Missouri
- +2 more
Jun 15, 2023